|3.||Wolff-Parkinson-White Syndrome (Wolf-Parkinson-White Syndrome)
|4.||Atrial Flutter (Flutter, Atrial)
|5.||Atrioventricular Nodal Reentry Tachycardia (AV Nodal Reentrant Tachycardia)
|1.||Drago, Fabrizio: 8 articles (11/2013 - 04/2005)|
|2.||Silvetti, Massimo Stefano: 5 articles (11/2013 - 09/2006)|
|3.||Glikson, Michael: 5 articles (06/2008 - 01/2003)|
|4.||Tuzcu, Volkan: 4 articles (10/2015 - 04/2007)|
|5.||De Santis, Antonella: 4 articles (05/2009 - 04/2005)|
|6.||Belhassen, Bernard: 4 articles (06/2008 - 01/2003)|
|7.||Zareba, Wojciech: 3 articles (12/2015 - 09/2005)|
|8.||Moss, Arthur J: 3 articles (12/2015 - 09/2005)|
|9.||Sommer, P: 3 articles (06/2015 - 04/2011)|
|10.||Andronache, Marius: 3 articles (11/2014 - 09/2003)|
|1.||Verapamil (Calan)FDA LinkGeneric
07/01/1991 - "In contrast, verapamil is markedly effective in the acute management of "supraventricular" tachycardias. "
12/15/1988 - "Verapamil was an effective treatment for acutely converting supraventricular tachycardia to sinus rhythm in these dogs. "
07/01/1988 - "Verapamil has been shown to be effective in the management of supraventricular tachycardia (SVT). "
12/01/1986 - "Verapamil is the treatment of choice (90% effective) for uncomplicated episodes of paroxysmal supraventricular tachycardia. "
04/01/1987 - "Intravenous verapamil is an effective and safe drug for the conversion of supraventricular tachycardia in children."
11/01/1992 - "Adenosine is a relatively new medication with an extremely short half-life and is effective in the treatment of supraventricular tachycardia. "
08/01/1991 - "In summary, adenosine is highly effective in terminating paroxysmal supraventricular tachycardia, and its very short half-life and benign side effects make it a promising alternative to other modes of therapy presently used. "
10/01/2012 - "To determine the optimal adenosine dose effective in supraventricular tachycardia (SVT) and underlying conditions affecting the effective dose in children. "
10/01/2012 - "Optimal dose of adenosine effective for supraventricular tachycardia in children."
03/01/2012 - "The clinical bottom line is there is strong evidence to support the efficacy of using adenosine as first-line treatment in patients who present to emergency departments with unstable paroxysmal supraventricular tachycardia."
|3.||Flecainide (Tambocor)FDA LinkGeneric
02/01/2002 - "Flecainide is safe and highly effective in the intrauterine treatment of hydropic fetuses with supraventricular tachycardia. "
01/01/1990 - "Based on the history and ECG flecainide had been effective in 51 pts. The improvement was most pronounced in pts suffering from supraventricular tachycardia involving an accessory bypass tract (84-92%). "
07/01/1986 - "The electrophysiologic effects and therapeutic efficacy of intravenous and oral flecainide were studied in 15 patients with spontaneous and inducible sustained paroxysmal supraventricular tachycardia (SVT). "
05/01/1995 - "Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia."
03/01/1987 - "This experience indicates that flecainide, which has not been used extensively in children, is an effective and safe antiarrhythmic agent, capable of terminating and controlling supraventricular tachycardia in children. "
|4.||Amiodarone (Amiodarona)FDA LinkGeneric
04/01/1988 - "A 3-week-old neonate with supraventricular tachycardia unresponsive to traditional therapy was treated successfully with amiodarone. "
10/01/1993 - "Combined triple-route administration of amiodarone to the fetus can be effective in treating supraventricular tachycardia and may have a role in the management of life-threatening fetal arrhythmias refractory to transplacental therapy."
02/09/1993 - "Considering some potential risk factors, amiodarone is an effective and safe antiarrhythmic agent for ventricular and supraventricular tachycardia. "
01/01/1984 - "This study evaluates whether the electrophysiologic effects of i.v. amiodarone in patients with reentrant supraventricular tachycardia (SVT) can predict the efficacy of long-term oral therapy with this drug. "
01/01/2001 - "We sought to assess the safety and efficacy of amiodarone as primary therapy for supraventricular tachycardia in infancy. "
|5.||Sotalol (Sotalol Hydrochloride)FDA LinkGeneric
11/01/1991 - "Sotalol, a nonselective beta blocking agent with additional Class III activity has been shown to be extremely effective in the treatment of supraventricular tachycardias in adults and children. "
12/01/2001 - "Sotalol was more effective in re-entrant type supraventricular tachycardias (P=0.012). "
09/01/1985 - "Thus, sotalol is effective in the therapy of patients with recurrent supraventricular tachycardias."
10/04/2005 - "Development of a safe and effective pediatric dosing regimen for sotalol based on population pharmacokinetics and pharmacodynamics in children with supraventricular tachycardia."
02/15/1992 - "The efficacy of intravenous sotalol (1 mg/kg) for suppressing inducibility of supraventricular tachycardias (SVT) with different electrophysiologic mechanisms was studied in 30 consecutive patients referred for an electrophysiologic study because of paroxysmal SVT. "
|6.||Diltiazem (Cardizem)FDA LinkGeneric
09/01/1985 - "Thus, 0.25 mg/kg of intravenous diltiazem produces a modest depression of AV nodal function and is not very effective in terminating supraventricular tachycardia or preventing its initiation in this study population. "
01/01/2007 - "Diltiazem is effective for ventricular rate control in this pacing model of supraventricular tachycardia. "
07/01/1995 - "Intravenous diltiazem is effective in converting supraventricular tachycardia to sinus rhythm. "
05/01/1989 - "Diltiazem, therefore, appears an effective and safe drug in the acute treatment of re-entrant supraventricular tachycardia."
04/01/1986 - "Intravenous diltiazem appears to be a safe and effective drug for the conversion of paroxysmal supraventricular tachycardia."
|7.||Propafenone (Rythmol)FDA LinkGeneric
07/01/1994 - "In addition, propafenone is very effective in young patients with supraventricular tachycardia based on enhanced abnormal automaticity. "
06/01/1989 - "In conclusion, propafenone is very effective in the control of paroxysmal supraventricular tachycardia; intravenous propafenone can predict the efficacy of oral therapy."
06/01/1989 - "The authors studied the efficacy of intravenous (IV) (1.5-2 mg/kg) and oral propafenone (450 to 900 mg/day) in 16 patients with paroxysmal, sustained, recurrent supraventricular tachycardia (SVT). "
11/01/2010 - "Propafenone, an antiarrhythmic drug that is effective for treating supraventricular tachycardias, can induce well-known proarrhythmic and systemic adverse effects. "
10/16/1998 - "Thus, propafenone is effective in terminating supraventricular tachycardias and AF in the vast majority of patients. "
|8.||Digoxin (Digitek)FDA LinkGeneric
02/01/1985 - "This study demonstrates that digoxin was effective in preventing significant spontaneous recurrences of supraventricular tachycardia in only 8/18 (44%) infants treated with digoxin. "
11/01/2001 - "Digoxin has been an effective treatment for fetal supraventricular tachycardia (SVT), but second-line therapy remains more controversial. "
10/01/1995 - "Comparison with previous natural history studies suggests that digoxin is ineffective in the prophylaxis of supraventricular tachycardia. "
04/01/1989 - "This study was conducted to ascertain if critical peak body stores of digoxin were needed to protect patients from the debilities that result from supraventricular tachycardias occurring after open heart operations. "
04/01/2005 - "Transplacental digoxin therapy successfully converted the supraventricular tachycardia to a normal sinus rhythm without evidence of maternal or fetal side-effects. "
|9.||Propranolol (Inderal)FDA LinkGeneric
07/01/1988 - "We conclude that continuous propranolol infusions appear safe and effective in treating these patients with supraventricular tachycardia."
07/01/1988 - "Because oral therapy is often contraindicated in hospitalized patients we assessed the safety and efficacy of continuous intravenous propranolol infusions in nine patients with refractory supraventricular tachycardia. "
07/15/2010 - "Four months later, oral propranolol hydrochloride 20 mg three times daily was initiated due to an episode of paroxysmal supraventricular tachycardia (PSVT). "
08/01/1996 - "Hemodynamic variables were evaluated in 10 patients during supraventricular tachycardia before and after administration of intravenous propranolol. "
08/01/1996 - "Effects of intravenous propranolol on cardiovascular hemodynamics during supraventricular tachycardia."
|10.||Disopyramide (Norpace)FDA LinkGeneric
03/01/1983 - "The objective of this study was to prove the efficacy of intravenous disopyramide in the treatment of paroxysmal supraventricular tachycardia resistant to vagal maneuvers. "
07/01/1990 - "Disopyramide was started on admission for supraventricular tachycardia. "
04/01/1984 - "[Effects of intravenous disopyramide on induction and termination of paroxysmal supraventricular tachycardia via an accessory pathway]."
06/01/1983 - "Paroxysmal supraventricular tachycardia could not be reinduced in six cases after disopyramide. "
06/01/1983 - "Anterograde slow pathway and fast pathway conduction properties were unchanged after disopyramide (atrial paced cycle length producing AH block 292 +/- 30 to 306.5 +/- 30 ms; effective refractory period of anterograde fast pathway less than or equal to 274 +/- 56 to 284 +/- 44 ms, before and after the drug, respectively) suggesting that anterograde conduction was not crucial either for sustainment or for failure to initiate paroxysmal supraventricular tachycardia after the drug. "
|1.||Drug Therapy (Chemotherapy)
05/03/1999 - "Radiofrequency ablation provides an effective cure for most patients with paroxysmal supraventricular tachycardia when the alternative is continuous drug therapy."
03/01/1999 - "Radiofrequency catheter ablation is highly effective in supraventricular tachycardia, with favorable cost-benefit analysis compared to lifelong antiarrhythmic drug therapy and should be considered as an initial option. "
05/01/2008 - "The aim of this study is to evaluate the long-term prognosis in infants affected by paroxysmal reciprocating supraventricular tachycardia (SVT), to identify predictors of SVT disappearance, and to assess the efficacy of electrophysiologically guided drug therapy in preventing recurrences. "
04/01/1994 - "There are relatively few well conducted clinical trials of the efficacy of drug therapy in supraventricular tachycardia. "
11/01/1994 - "This study evaluated the cost of performing radiofrequency catheter ablation in Japanese patients with paroxysmal supraventricular tachycardia refractory to antiarrhythmic drug therapy in comparison with the cost of continuing pharmacologic treatment. "
|2.||Electric Countershock (Cardioversion)
01/01/1991 - "In treating paroxysmal supraventricular tachycardia in pregnancy, when both vagal maneuvers and exhaustive medical therapy fail, synchronized, direct-current cardioversion is a safe and effective form of treatment."
01/01/2014 - "Modified Valsalva manoeuvre to treat recurrent supraventricular tachycardia: description of the technique and its successful use in a patient with a previous near fatal complication of DC cardioversion."
01/01/2012 - "Successful electrical cardioversion of supraventricular tachycardia in a pregnant patient."
01/01/2006 - "Although cardioversion was required to treat supraventricular tachycardia in the early period after surgery, the patient was discharged from hospital and remains in good clinical condition at the last follow-up at 5 years with normal sinus rhythm and good biventricular function."
12/01/2005 - "She had an incessant supraventricular tachycardia, which was not reversible with electrical cardioversion. "
02/01/2011 - "To review the clinical experience, complications and outcome of Cardiac Electrophysiology Studies and Catheter Radiofrequency Ablation in treatment of supraventricular tachycardias in Karachi. "
04/01/2007 - "This study demonstrates that nonfluoroscopic electrophysiologic studies and right-sided catheter ablations for supraventricular tachycardia can be safely and effectively performed in the majority of patients with normal cardiac anatomy using NavX. "
05/22/1978 - "Catheter recording of Bachmann's bundle activation from the right pulmonary artery: a new technique for atrial mapping and the study of supraventricular tachycardia."
01/01/2012 - "Catheter ablations of supraventricular tachycardias."
11/01/2010 - "Recent advances in the ability of EAM systems to simultaneously visualize multiple catheters have allowed some operators to perform certain procedures, such as catheter ablation of supraventricular tachycardias, with zero fluoroscopy use. "
09/01/2006 - "Cryoablation is an effective treatment for children with supraventricular tachycardias (SVT). "
04/01/2010 - "Cryoablation is an effective and safe treatment for children with supraventricular tachycardias when the reentry circuit is located near the atrioventricular (AV) junction. "
09/01/2006 - "Lengthier cryoablation and a bonus cryoapplication is associated with improved efficacy for cryothermal catheter ablation of supraventricular tachycardias in children."
11/01/2013 - "The aim of this study was to report the 10-year experience of our Institution in cryoablation of supraventricular tachycardia due to a right accessory pathway (AP). "
01/01/2013 - "The aim of this study was to evaluate the indications, results and complications of radiofrequency ablation (RFA) and transcatheter cryoablation (TCA) in neonates and infants with incessant drug-resistant supraventricular tachycardia (SVT). "
06/01/2015 - "The efficacy of carotid sinus massage in terminating supraventricular tachycardia appears to be modest at best. "
01/01/1998 - "To compare the efficacy of the Valsalva maneuver with that of carotid sinus massage (CSM) in terminating paroxysmal supraventricular tachycardia (SVT) in the ED. "
06/01/2015 - "A search using PubMed, Ovid, and COCHRANE databases was performed using the terms supraventricular tachycardia, carotid sinus massage, SVT, and CSM. "
06/01/2015 - "The objectives of our investigation were to review the evidence for the efficacy and safety of carotid sinus massage in terminating supraventricular tachycardia and to determine if other potentially less harmful interventions have been established to be safer and more effective. "
06/01/2015 - "Reconsidering the effectiveness and safety of carotid sinus massage as a therapeutic intervention in patients with supraventricular tachycardia."